EMEA-000093-PIP01-07-M01
Key facts
| Active substance |
Sotrastaurin acetate
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/155/2011
|
| PIP number |
EMEA-000093-PIP01-07-M01
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of chronic plaque psoriasis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Novartis Europharm Ltd
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|